AstraZeneca(AZN)
AstraZeneca plc (/ˌæstrəˈzɛnəkə/) is a British-Swedish multinational pharmaceutical and biotechnology company with its headquarters at the Cambridge Biomedical Campus in Cambridge, England. It has a portfolio of products for major diseases in areas including oncology, cardiovascular, gastrointestinal, infection, neuroscience, respiratory, and inflammation. It has been involved in developing the Oxford–AstraZeneca COVID-19 vaccine.
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
*Currency in USD
Company Revenue
Quarterly
Quarterly
Annual
Annual
Projections
Mock data
Subscribe for the real data
Subscribe for the real data
Revenue by Drug
Marketed Drugs
Therapeutic Areas:
All
Classification:
All
Include Generics:
Trade Name | Drug Name | Approved | Patent Expires | Indication |
|---|---|---|---|---|
| Aquasol a | Vitamin a | 1982-01-01 | — | |
| Bevespi aerosphere | Formoterol, Glycopyrrolate, Formoterol dihydrate, Glycopyrronium | 2016-04-25 | 2023-2038 | |
| Beyfortus | Nirsevimab | 2023-07-17 | — | |
| Bretylium | Bretylium | 1987-08-10 | ||
| Breztri aerosphere | Budesonide, Formoterol, Glycopyrrolate | 2020-07-23 | 2024-2043 | |
| Brilinta | Ticagrelor | 2011-07-20 | 2024-2036 | |
| Brilique | Ticagrelor | 2010-12-03 | 2024-2036 | |
| Bydureon | Exenatide, Exenatide synthetic | 2011-06-17 | 2024-2030 |
1
2
3
4
5
6
...
10
>
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name | Phase 1 | Phase 2 | Phase 3 | Phase 4 | Indication |
|---|---|---|---|---|---|
1
2
3
4
5
6
...
22
>
© 2020-2023 Collaborative Drug Discovery Inc. (CDD) | Terms of Use